These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 19408414
1. Open channels: Do new cystic-fibrosis therapies hold the key to treating other genetic disorders? Groopman J. New Yorker; 2009 May 04; ():30-4. PubMed ID: 19408414 [No Abstract] [Full Text] [Related]
2. Genetics. The promise of a cure: 20 years and counting. Couzin-Frankel J. Science; 2009 Jun 19; 324(5934):1504-7. PubMed ID: 19541969 [No Abstract] [Full Text] [Related]
3. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living? Elliott C. New Yorker; 2008 Jan 07; ():36-41. PubMed ID: 18265451 [No Abstract] [Full Text] [Related]
4. The story so far in R&D. Prous JR, Khurdayan VK. Drug News Perspect; 2007 Jan 07; 20(1):7-15. PubMed ID: 17332897 [Abstract] [Full Text] [Related]
5. The right to a trial: Should dying patients have access to experimental drugs? Groopman J. New Yorker; 2006 Dec 18; ():40-7. PubMed ID: 17176539 [No Abstract] [Full Text] [Related]
6. [Gene therapy of mucoviscidosis]. Rochat T. Rev Med Suisse Romande; 1996 May 18; 116(5):345-9. PubMed ID: 8693270 [No Abstract] [Full Text] [Related]
8. Human genetics: One gene, twenty years. Pearson H. Nature; 2009 Jul 09; 460(7252):164-9. PubMed ID: 19587741 [No Abstract] [Full Text] [Related]
9. Five decades of cystic fibrosis (1938-1988). Kulczycki LL. Acta Univ Carol Med (Praha); 1990 Jul 09; 36(1-4):7-12. PubMed ID: 2130723 [No Abstract] [Full Text] [Related]
10. [Demographic growth and targeted therapies: The changing face of cystic fibrosis]. Fajac I, Burgel PR. Rev Mal Respir; 2016 Oct 09; 33(8):645-647. PubMed ID: 26777401 [No Abstract] [Full Text] [Related]
11. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects. Pringle IA, Hyde SC, Gill DR. Expert Opin Biol Ther; 2009 Aug 09; 9(8):991-1003. PubMed ID: 19545217 [Abstract] [Full Text] [Related]
12. A millennial view of cystic fibrosis. Dodge JA. Dev Period Med; 2015 Aug 09; 19(1):9-13. PubMed ID: 26003065 [Abstract] [Full Text] [Related]
13. The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases. Goss CH, Mayer-Hamblett N, Kronmal RA, Ramsey BW. Adv Drug Deliv Rev; 2002 Dec 05; 54(11):1505-28. PubMed ID: 12458158 [Abstract] [Full Text] [Related]
14. Isolating the cystic fibrosis gene and possibilities for treatment. Buchwald M. Del Med J; 1990 Oct 05; 62(10):1275-8, 1281. PubMed ID: 2286285 [No Abstract] [Full Text] [Related]
15. [Cystic fibrosis]. Suter S. Rev Med Suisse Romande; 1997 Dec 05; 117(12):927-8. PubMed ID: 9481163 [No Abstract] [Full Text] [Related]
16. Design of gene therapy clinical trials in CF patients. Curlee KV, Sorscher EJ. Methods Mol Med; 2002 Dec 05; 70():575-84. PubMed ID: 11917552 [No Abstract] [Full Text] [Related]
17. Perspectives in gene therapy. Geddes D. Pediatr Pulmonol; 2001 Dec 05; Suppl 23():97-9. PubMed ID: 11886165 [No Abstract] [Full Text] [Related]
18. 50 Years ago in the Journal of Pediatrics: a 5-year clinical evaluation of therapeutic program for patients with cystic fibrosis. Toltzis P. J Pediatr; 2014 Nov 05; 165(5):966. PubMed ID: 25441386 [No Abstract] [Full Text] [Related]
19. A Personal Reflection from London. Thrasher AJ. Hum Gene Ther; 2017 Nov 05; 28(11):959. PubMed ID: 29035116 [No Abstract] [Full Text] [Related]
20. [Clinical research with new drugs]. Oberholzer RJ. Pharm Acta Helv; 1968 Sep 05; 43(9):550-71. PubMed ID: 4887984 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]